Dental Pharmacology & Safety

Nano-Diamonds: A Ray Of Hope Against Antibiotic Resistance.

Diamond nano-particles, namely, nano-diamonds (NDs) with many promising physico-chemical properties, have been demonstrated to work as an effective...

Dr. Rockson Samuel

Dr. Rockson Samuel

Founder & Chief Dentist · Indira Dental Clinic; DentalReach

2 min read138,017 views
  • biofilm inhibition
  • professional education
  • nano-diamonds
  • oral infections
  • dentistry
  • antibacterial
  • biofilm
  • nanotechnology
  • Dental Pharmacology & Safety
  • Clinical & Academic Article
Contents

Diamond nano-particles, namely, nano-diamonds (NDs) with many promising physico-chemical properties, have been demonstrated to work as an effective antibacterial agent against planktonic cells (free-floating state).

Nanotechnology is being intensively explored nowadays to provide more efficient therapeutics as there is a constant increase in antibiotic resistance. The complex microbial communities which are the main cause for oral infections show particularly high resistance to conventional antibiotics.

Nano-diamonds work as an effective agent against both free-floating cells (planktonic cells) and attached cells (biofilm) of bacteria and fungi that are highly relevant in oral and systemic infections (Image: HKU)

In a journal article published in Biomaterials Science ("Biofilm inhibition in oral pathogens by nanodiamonds"), scientists from the Faculty of Engineering and the Faculty of Dentistry of the University of Hong Kong (HKU) revealed for the first time the inhibitory effect on oral pathogenic biofilms by high-pressure high-temperature (HPHT) nano-diamonds.

In particular, they uncovered the role of NDs in inhibiting biofilm formation and their disrupting effect on preformed biofilms in several selected orally and systemically important organisms.

“Nano-materials are the hot topic in current materials science as these ultra-small particles can effectively penetrate into microorganisms and can also be used to carry a wide variety of drugs. Our research showed that these ultra-small nano-diamonds can manipulate genetic mechanisms in the pathogens and prevent their attachment to any surface, hence inhibiting biofilm formation in the oral cavity,” explained Dr Chu and Dr Neelakantan.

“The results of this exciting study demonstrated the great potential of NDs as an alternative therapeutic platform to prevent and treat oral infections. NDs possess many promising features including excellent biocompatibility and flexible surface properties. They are also proven to be very safe for humans. Our work will promote a better mechanistic understanding of NDs on oral pathogens, paving the way for their clinical and translational applications,” they added.

Since fungal cells are very similar to human cells, developing antifungal agents that are not harmful to humans has always been a major challenge. In such situations, studies like this shows promises a better future for dental medicine.

References

  1. [1]American Dental Association. Acute Dental Pain Management Guideline ADA Clinical Guidelines. 2024. Available at: source
  2. [2]Lockhart PB, Tampi MP, Abt E, et al.. Evidence-based clinical practice guideline on antibiotic use for urgent management of pulpal- and periapical-related dental pain and intraoral swelling Journal of the American Dental Association. 2019. Available at: source

Written by

Dr. Rockson Samuel

Dr. Rockson Samuel

Founder & Chief Dentist · Indira Dental Clinic; DentalReach

Dr. Rockson Samuel is a dental surgeon, healthcare content strategist, and Founder and Chief Dentist of Indira Dental Clinic in Vellore, Tamil Nadu. He provides comprehensive general and family dental care with professional interests in endodontics, implant dentistry, clear aligner therapy, digital dentistry, preventive care and patient education. A graduate of K.G.F. College of Dental Sciences and Hospital under Rajiv Gandhi University of Health Sciences, he also has formal training in management and digital marketing. As Community Leader at DentalReach, he contributes to dental publishing, professional education, international media partnerships and the development of evidence-informed resources for dentists.